socalTECH

JULY 31, 2013

One of the companies that has recently is On Ramp Wireless (www.onrampwireless.com), a San Diego company in the M2M market headed by Kevin Hell. Our initial target is with utilities, with oil and gas next, and lots of other markets which are getting traction. It''s really a broad set of applications.

Technical Review 213

Technical Review Software Review Networking Technology 213

socalTECH

APRIL 16, 2010

One of the types of startups we see most of nowadays, are private sale, limited time bargain, and local group buying startups. There is lots and lots of competition in the area, how is your firm different from the others? We cater to a more specific market, and get deals specifically for those verticals.

Orange County 170

Orange County Startup Sites Southern California 170

socalTECH

OCTOBER 10, 2013

Michael Kleist: My business partner and I were both originally from San Diego. We''ll mostly be doing enterprise sales here, but also looking at the technology and design front, hiring better talent, taking design to a new level than maybe what we are in China. It''s also a dog-eat-dog world over there with the competition.

Southern California 170

Southern California Startup SoCal CTO Hire 170

Xconomy

JULY 19, 2016

In general, M&A is a natural part of the IT security market. It’s why this market segment is so attractive to venture investors. Symantec Forces the Industry to Stay Competitive. For 2015, there were 133 information security M&A deals, according to 451 Research’s Tech M&A Outlook 2016. Why is this happening?

Symantec 40

Symantec IBM IBM Acquisition 40

Both Sides of the Table

JULY 6, 2015

Many people are too cautious in sales processes and as a result when they present their solutions they end up sounding milquetoast and undifferentiated from anybody else in the market. I recently wrote about the three rules of sales. Assume competition and assume within the buying organization you have enemies.

Sales 150

Sales SaaS Startup Venture Capital 150

Xconomy

OCTOBER 18, 2016

Sales of both drugs, ivacaftor (Kalydeco) and the combo pill ivacaftor-lumacaftor (Orkambi), reached almost $1 billion in 2015 and are growing. But the drugs aren’t cures, and competition looms. Telaprevir sales rocketed to nearly $1 billion in the first six months, at the time the fastest drug launch ever.

Startup 40

Startup Research Sales Organization 40

Both Sides of the Table

OCTOBER 19, 2009

After my company was acquired by Salesforce.com I was asked to stop blogging and they took over my blog as an asset in the sale of the company. They looked nervous at having to speak with me impromptu and without the benefit of financial figures to scoff at, product pitches that they’ve seen 100 times and a market sizing to unpick.

Venture Capital 274

Venture Capital Blogging Startup Slides 274

socalTECH

SEPTEMBER 19, 2008

We seem to receive lots of pitches from companies looking to attack the mobile market with their mobile software applications, but few who have deployed on-deck with carriers. Derrick Oien: The primary market is the operator. It all depends on the carrier and their target market. So we sell into the carriers.

Social Network 113

Social Network Anthem Mobile Java 113

Both Sides of the Table

JANUARY 1, 2016

In fact, 50% of our investments are in Southern California, from Santa Barbara to San Diego. But putting no time into anchoring your beliefs because you’re too busy executing sales, marketing, support, product & engineering is an easy recipe for leadership drift. We could all do better – I’m sure.

Startup 150

Startup Coach Course Invest 150

socalTECH

NOVEMBER 25, 2008

San Diego-based Awarepoint (www.awarepoint.com) is a developer of systems for tracking hospital assets, patients, and doctors, using RFID tags. We were over 2x up on this round, and we also had a bunch of individual investors who wanted to put in--people who had invested in our competition a few years ago. Congrats on funding.

Startup 113

Startup CTO Hire Resource Venture Capital 113

Xconomy

AUGUST 26, 2016

Critics say Mylan has been emboldened by the recall of EpiPen’s only competition last fall. Two days later, it paid AstraZeneca $550 million upfront for the rights to a group of antibiotics either already on the market or in late-stage testing.

Pricing 40

Pricing Thousand Oaks Startup Research 40

Both Sides of the Table

FEBRUARY 15, 2011

If you are talented, of course, you can get funded in any region with enough venture capital and obviously in markets outside of the Valley it is easier to get noticed and get access. It’s hard to get people to take a risk at a startup or for a reasonable salary with all this competition. Hit some bumps in the road?

Venture Capital 313

Venture Capital Southern California Google Startup 313

Both Sides of the Table

JANUARY 31, 2010

TechCrunch Europe ran an article in November of last year that European startups need to work as hard as those in Silicon Valley and I echoed the sentiment in my post about the need for entrepreneurs to be maniacal about their businesses if one wants to work in the hyper competitive tech world. Our first big institutional round was $16.5

Entrepreneur 308

Entrepreneur Startup Venture Capital Conference 308

Xconomy

MAY 10, 2019

The market for drugs for rare or “orphan” diseases continues to grow. An April report from Evaluate Pharma predicted sales of orphan drugs to rise 12 percent a year between now and 2024, when they will account for an estimated 20 percent of worldwide prescription drug sales. Soon there could be three.

Pricing 97

Pricing Sales Competition Report 97

Xconomy

JULY 29, 2016

But the company said this week that sales of Sovaldi and Harvoni, which share a common ingredient, sofosbuvir, have slowed with fewer patients starting on the drugs and prices undercut by fierce competition from AbbVie and Merck. How about we start a pool? Speaking of pools, we need to jump in one to cool off. .

Startup 40

Startup Study News Report 40